期刊文献+

羟考酮与舒芬太尼用于全麻诱导时患者对双腔支气管导管插管反应和切皮反应的比较 被引量:17

Comparison of oxycodone and sufentanil used for anesthesia induction in inhibiting responses to tracheal intubation with double-lumen endobronchial tube and skin incision
原文传递
导出
摘要 目的:比较等效剂量盐酸羟考酮注射液与枸橼酸舒芬太尼注射液用于全麻诱导时,患者对双腔支气管导管插管反应和切皮反应的不同。方法:择期全麻下拟行单肺通气胸科手术患者60例,性别不限,年龄45~60岁,体重50~80 kg,ASAⅠ或Ⅱ级,非困难气道,采用随机数字表法分为2组(n=30)。全麻诱导分别静脉注射盐酸羟考酮0.30 mg·kg^(-1)(O组)及枸橼酸舒芬太尼0.30μg·kg^(-1)(S组),随后两组均静脉注射异丙酚2.0~2.5 mg·kg^(-1)和顺式阿曲库铵0.25 mg·kg^(-1),双腔支气管导管插管后行机械通气,七氟醚维持,切皮前不再追加镇痛药。分别于麻醉诱导前(T0)、气管插管前即刻(T1)、气管插管后即刻(T2)、气管插管后5 min(T3)和切皮(T4)时记录生命体征以及呛咳、体动反应的发生情况。结果:T2时O组血压和心率较T0时无明显变化,S组则有显著升高(P≤0.001);与O组比较,S组T2插管时血压和心率波动较大(P≤0.001)。两组切皮时血压、心率均没有显著升高,两组均未出现呛咳和体动反应。结论:相比等效剂量舒芬太尼,全麻诱导静脉注射盐酸羟考酮0.30 mg·kg^(-1)可以更有效地抑制患者对双腔支气管导管的插管反应。 Objective: To compare oxycodoneand sufentanil used for anesthesia induction in inhibiting responses to tracheal intubation with double-lumen endobronchial tube and skin incision. Methods: Sixty adult patients (aged 45 - 60 years, weighting 50 - 80 kg, with ASA physical status I or 11 , without difficult airway, scheduled for elective thoracic surgery requiring one-lung ventilation) were randomly divided into oxycodone group (n = 30) and sufentanil group (n = 30) using a random number table. Anesthesia was induced with iv oxyeodone 0.30 mg. kg - 1 ( oxycodone group) or sufentanil 0.30 I^g" kg- 1 ( sufentanil group) , respectively, together with iv propofol 2.0 - 2. 5 rag" kg-1 and cisatracurium 0.25 mg ~ kg-1 The patients were tracheally intubated using a double-lumen endobronchial tube and mechanically ventilated. Anesthesia was maintained with sevoflurane, and no anagelsic was added before skin incision. Before anesthesia induction (T0), immediately before intubation (T1) and after intubation (T2), 5 rain after intubation (T3), and immediately after skin incision (T4), mean arterial pressure (MAP) , heart rate (HR), and the occurrence of bucking and body movement were observed. Results:MAP and HR were significantly increased at T2 as compared with T1 in sufentanil group (P≤0. 001 ) , while there was no significant difference in oxycodone group. Compared with oxycodone group, the fluctuation of MAP and HR were significantly increased in sufentanil group at T2 (P≤0. 001 ). There was no significant elevation of MAP and HR at T4, and no incidence of bucking and body movement during the observation in both groups. Conclusion: Compared with sufentanil, oxycodone (0. 30 mg·kg-1) used for anesthesia induction can effectively inhibit responses to tracheal intubation with double-lumen endobronchial tube.
作者 丁蕾 陈冀衡
出处 《中国新药杂志》 CAS CSCD 北大核心 2016年第17期1979-1983,共5页 Chinese Journal of New Drugs
关键词 羟考酮 舒芬太尼 插管 双腔支气管导管 切皮 血液动力学 应激反应 oxycodone sufentanil intubation double-lumen endobronchial tube skin incision hemodynamics stress response
  • 相关文献

参考文献4

二级参考文献29

  • 1尧新华,刘继云,周朴,王保,肖珍科,陈陈燕,曾维安,卿朝辉,鲁义.舒芬太尼复合艾司洛尔对全麻患者气管插管时心血管反应的影响[J].中华麻醉学杂志,2007,27(10):890-892. 被引量:7
  • 2Pasternak GW.Molecular biology of opioid analgesia.J Pain Symptom Manage,2005,29(5 Suppl):S2-9.
  • 3Andreassen TN,Klepstad P,Davies A,et al.Is oxycodone efficacy reflected in serum concentrations? A multicenter,cross sectional study in 456 adult cancer patients.J Pain Symptom Manage,2012,43(4):694-705.
  • 4Staahl C,Dimcevski G,Andersen SD,et al.Different effect of opioids in patients with chronic pancrdatitis:an experimental pain study.Scand J Ganstroenterol,2007,42(3):383-390.
  • 5Davis MP,Varga J,Dickerson D,et al.Normal-release and controlled release oxycodone:pharmacokinetics,pharmacodynamics,and controversy.Support Care Cancer,2003,11(2):84-92.
  • 6King SJ,Reid C,Forbes K,et al.A systematic review of oxycodone in the management of cancer pain.Palliat Med,2011,25(5):454-470.
  • 7King S1,Forbes K,Hanks GW.A systematic review of the use of opioid medication for those with moderate to severe cancer pain and renal impairment:a European Palliative Care Research Collaborative opioid guidelines project.Palliat Med,2011,25(5):525-552.
  • 8Lazzari M,Sabato AF,Caldarulo C,et al.Effectiveness and tolerability of low dose oral oxycodone/naloxone added to anticonvulsant therapy for noncancer neuropathic pain:an observational analysis.Curr Med Res Opin,2014,30(4):555-564.
  • 9McNicol ED,Midbari A,Eisenberg E.Opioids for neuropathic pain.Cochrane Database Syst Rev,2013,8:CD006146.
  • 10Lancaster T,McQuay H.Review:tricyclic antidepressants,capsaicin,gabapentin,and oxycodone are effective for postherpetic neuralgia.ACP J Club,2002,137(2):52.

共引文献488

同被引文献140

引证文献17

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部